Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study
Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 32, pp. 3231-3239
Open Access | Times Cited: 132

Showing 26-50 of 132 citing articles:

Prevalence of pre-existing cognitive impairment in patients treated for cancer and the impact of cancer treatment on cognitive outcomes: A scoping review
Nelly Toledano, Valentina Donison, Avital Sigal, et al.
Journal of Geriatric Oncology (2025) Vol. 16, Iss. 4, pp. 102235-102235
Closed Access
Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors
Danielle B. Tometich, Brent J. Small, Judith Carroll, et al.
Journal of Pain and Symptom Management (2018) Vol. 57, Iss. 3, pp. 596-606
Open Access | Times Cited: 41
Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research
Andrew J. Levine, Ned Sacktor, James T. Becker
Journal of NeuroVirology (2020) Vol. 26, Iss. 6, pp. 809-823
Open Access | Times Cited: 38
Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study
Mylène Duivon, Justine Lequesne, Antonio Di Meglio, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4
Towards Excellence: Virtue and the Principle of Autonomy in Informed Consent for Clinical Trials
Alexander Montes
The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine (2025)
Closed Access
Meta-analyses of executive function deficits in chemotherapy-treated rodent models
Weiye Chen, Ian N. Johnston
Neuroscience & Biobehavioral Reviews (2025), pp. 106131-106131
Open Access
Cognitive Rehabilitation for Cognitive Dysfunction after Cancer and Cancer Treatment: Implications for Nursing Practice
Diane Von Ah, Adele Crouch
Seminars in Oncology Nursing (2020) Vol. 36, Iss. 1, pp. 150977-150977
Open Access | Times Cited: 29
Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy
Michelle C. Janelsins, Mostafa Mohamed, Luke J. Peppone, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 114, Iss. 1, pp. 47-59
Open Access | Times Cited: 26
The longitudinal relationship between immune cell profiles and frailty in patients with breast cancer receiving chemotherapy
Nikesha Gilmore, Supriya G. Mohile, Lianlian Lei, et al.
Breast Cancer Research (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 25
Preoperative Cognitive Impairment and the Prevalence of Postoperative Delirium in Elderly Cancer Patients—A Prospective Observational Study
Irina Ristescu, Georgiana Pintilie, Mihaela Moscalu, et al.
Diagnostics (2021) Vol. 11, Iss. 2, pp. 275-275
Open Access | Times Cited: 24
Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After Chemotherapy
Elizabeth Belcher, Eva Culakova, Nikesha Gilmore, et al.
JNCI Journal of the National Cancer Institute (2022) Vol. 114, Iss. 5, pp. 712-721
Open Access | Times Cited: 18
Evidence of brain-derived neurotrophic factor in ameliorating cancer-related cognitive impairment: A systematic review of human studies
Ding Quan Ng, Daniella Chan, Parisa Agrawal, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103748-103748
Open Access | Times Cited: 17
Randomized double-masked controlled trial of cognitive training in breast cancer survivors: a preliminary study
Diane Von Ah, Brenna C. McDonald, Adele Crouch, et al.
Supportive Care in Cancer (2022) Vol. 30, Iss. 9, pp. 7457-7467
Open Access | Times Cited: 16
A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects
Zev M. Nakamura, Allison M. Deal, Eliza M. Park, et al.
Cancer Medicine (2023) Vol. 12, Iss. 7, pp. 8172-8183
Open Access | Times Cited: 10
Cognitive adverse events in patients with lung cancer treated with checkpoint inhibitor monotherapy: a propensity score-matched analysis
Yifei Ma, Nianqi Liu, Yanqi Wang, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101987-101987
Open Access | Times Cited: 10
Care needs of older patients with advanced cancer
Alex Molassiotis, Mian Wang
Current Opinion in Supportive and Palliative Care (2023) Vol. 17, Iss. 1, pp. 31-36
Closed Access | Times Cited: 9
Medical Decision-Making in Oncology for Patients Lacking Capacity
Jonathan M. Marron, Kaitlin Kyi, Paul S. Appelbaum, et al.
American Society of Clinical Oncology Educational Book (2020), Iss. 40, pp. e186-e196
Open Access | Times Cited: 27
Effectiveness of a Computerized Home-Based Cognitive Stimulation Program for Treating Cancer-Related Cognitive Impairment
Jose L. Tapia, María Teresa Taberner-Bonastre, David Collado-Martínez, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 6, pp. 4953-4953
Open Access | Times Cited: 8
Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting‐state fMRI
Senbang Yao, Qinqin Zhu, Qianqian Zhang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 15, pp. 16231-16242
Open Access | Times Cited: 8
Improve the management of cancer-related cognitive impairment in clinical settings: a European Delphi study
Mylène Duivon, Marie Lange, Giulia Binarelli, et al.
Journal of Cancer Survivorship (2023) Vol. 18, Iss. 6, pp. 1974-1997
Open Access | Times Cited: 8
Associations of inflammation with frailty in patients with breast cancer aged 50 and over receiving chemotherapy
Nikesha Gilmore, Sindhuja Kadambi, Lianlian Lei, et al.
Journal of Geriatric Oncology (2019) Vol. 11, Iss. 3, pp. 423-430
Open Access | Times Cited: 24
A randomised wait-list controlled trial to evaluate Emotional Freedom Techniques for self-reported cancer-related cognitive impairment in cancer survivors (EMOTICON)
Laura Tack, Tessa Lefebvre, Michelle Lycke, et al.
EClinicalMedicine (2021) Vol. 39, pp. 101081-101081
Open Access | Times Cited: 18
Cancer-Related Cognitive Dysfunction: A Narrative Review for Clinical Practice
Oliver Rick, Alexandra Gerhardt, Georgia Schilling
Oncology Research and Treatment (2024) Vol. 47, Iss. 5, pp. 218-223
Closed Access | Times Cited: 2
Ergotherapie in Onkologie und onkologischer Rehabilitation
Timm Dauelsberg, Sabrina Heizmann
Im Focus Onkologie (2024) Vol. 27, Iss. 1, pp. 32-37
Closed Access | Times Cited: 2
A scoping review evaluating physical and cognitive functional outcomes in cancer survivors treated with chemotherapy: charting progress since the 2018 NCI think tank on cancer and aging phenotypes
Mostafa Mohamed, Mustafa M. Ahmed, AnnaLynn M. Williams, et al.
Journal of Cancer Survivorship (2024) Vol. 18, Iss. 4, pp. 1089-1130
Open Access | Times Cited: 2

Scroll to top